Antifungal activity of Limosilactobacillus reuteri against Candida albicans and non-Candida albicans Candida
Science Letters · 25.04.2024
DOI: 10.48797/sl.2024.168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Letters, erschienen am 25.04.2024. Verfasst von António Rajão und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Oral candidiasis is one of the most present fungal infections, with Candida albicans being the foremost responsible for this infection, but in recent years the non-Candida albicans Candida species play a significant role in the rise of cases of oral candidiasis [1]. Phenomena of resistance to regular antifungals are rising, which makes it harder to control cases of oral candidiasis. Thus, searching for new approaches like probiotics, and their use in the oral cavity, becomes necessary and urgent [2]. Here we present the antifungal activity of newly isolated oral strain of Limosilactobacillus reuteri, a potential probiotic.
Objective
Evaluation of Limosilactobacillus reuteri AJCR antifungal activity against reference strains of Candida spp..
Methods
Limosilactobacillus reuteri AJCR was isolated from the oral cavity of a healthy, caries free, volunteer, following the methodology of Rossini et al. [2]. Four reference strains, Candida albicans SC14, Nakaseomyces glabrata ATCC2001, C. tropicalis ATCC750, and C. parapsilosis ATCC22019, were used to evaluate the antifungal activity in planktonic cells. The methodology followed was adapted from the EUCAST guidelines. Different amounts of L. reuteri (108-102 CFU/mL, final concentration) were added, to standardized suspensions of the Candida strains studied.
Results
At L. reuteri concentration of 108 CFU/mL, no viable cells of C. albicans SC5314 and of C. tropicalis ATCC750 were detected. At the same concentration, Nakaseomyces glabrata ATCC2001 suffered a reduction in growth of around 4 Log. Candida parapsilosis ATCC22019 suffered a reduction of around 2 Log at concentration of 107 CFU/mL of the oral isolate.
Conclusions
Limosilactobacillus reuteri AJCR has shown an excellent antifungal activity against planktonic cells of C. albicans SC5314 and C. tropicalis ATCC750, and a significant reduction in the growth of Nakaseomyces glabrata ATCC2001 and C. parapsilosis ATCC22019. To further characterize the antifungal activity of the isolate, studies with biofilm cultures must be performed.
Schlagwörter
Zitieren
APA
Rajão, A., Rompante, P., Rodrigues, C. F., & Andrade, J. C. (2024). Antifungal activity of Limosilactobacillus reuteri against Candida albicans and non-Candida albicans Candida. Science Letters. https://doi.org/10.48797/sl.2024.168
Vancouver
Rajão A, Rompante P, Rodrigues CF, Andrade JC. Antifungal activity of Limosilactobacillus reuteri against Candida albicans and non-Candida albicans Candida. Science Letters. 2024. doi:10.48797/sl.2024.168
BibTeX
@article{Rajo2024,
author = {Rajão, António and Rompante, Paulo and Rodrigues, Célia F. and Andrade, José Carlos},
title = {Antifungal activity of Limosilactobacillus reuteri against Candida albicans and non-Candida albicans Candida},
journal = {Science Letters},
year = {2024},
doi = {10.48797/sl.2024.168}
}
EUVIMED